Figma Shares Indicated To Open $105/$110
Mary Beth DeNooyer, Chief Human Resources Officer at Keurig Dr Pepper Inc. (NASDAQ:KDP), recently sold 12,000 shares of the company’s common stock. The sale, part of a pre-established Rule 10b5-1 trading plan, was executed on April 1, 2025, at a weighted average price of $34.78 per share, totaling approximately $417,360. The transaction occurred as KDP, currently valued at $48.29 billion, trades near $35.63 per share. According to InvestingPro analysis, the stock appears slightly overvalued at current levels. Following this transaction, DeNooyer holds 166,511 shares directly. The shares were sold in multiple transactions, with prices ranging from $34.43 to $35.12. The company maintains a GOOD financial health score and offers a 2.62% dividend yield. InvestingPro subscribers can access 8 additional key insights and a comprehensive Pro Research Report, providing deeper analysis of KDP’s valuation and growth prospects.
In other recent news, Keurig Dr Pepper has been the subject of several notable developments. The company reported a significant change in its board composition following the resignation of three board members affiliated with JAB BevCo B.V., coinciding with the completion of a substantial public secondary offering. This offering involved the sale of 73 million shares, resulting in gross proceeds of approximately $2.7 billion, although Keurig Dr Pepper did not receive any proceeds from this transaction. Analysts from Morgan Stanley (NYSE:MS) upgraded the company’s stock rating from ’Equalweight’ to ’Overweight,’ raising the price target to $40.00, citing strong growth prospects in the US Refreshment segment and solid international performance. Jefferies also increased its price target for Keurig Dr Pepper shares to $41, maintaining a Buy rating, and praised the company’s strong finish to 2024, noting that both organic growth and earnings per share exceeded expectations. Meanwhile, a proposal to ban the purchase of soda with food stamps has gained traction, raising concerns about potential impacts on the beverage industry’s sales, including Keurig Dr Pepper. Despite these regulatory challenges, the company remains focused on its strategic commercial plans and innovation efforts to drive future sales.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.